Gene therapy to prevent vascular remodeling-vascular smooth muscle cell as a target cell
Gene therapy to prevent vascular remodeling-vascular smooth muscle cell as a target cell
批准号:
14570663
负责人:
TANIGUCHI Takahiro
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Vascular smooth muscle cell (VSMC) migration, proliferation, and matrix synthesis within the intima of vessels play an important role in post-angioplasty restenosis. Coronary artery restenosis remains a major unresolved limitation for interventional cardiology. It results from arterial injury incurred during coronary vascularization and is caused in large part bu neointimal hyperplasia, especially within stents. To develop a new therapeutic strategy, we performed following studies. Akt (PKB) is a serine-threonine protein kinase that is activated by various extracellular stimuli through the phosphatidylinositol 3-kinase (P1 3-kinase) pathway. Akt plays an important role in apoptosis, cell proliferation, glucose metabolism and angiogenesis. VSMCs have three isoforms of myosine heavy chains : SM 1,SM 2 and SM emb. After angioplasty, VSMCs change their phenotype from differentiated phenotype (SM 1 and SM 2) to dedifferentiated one (SM emb). Akt regulates these VSMC phenotypic changes. Aden … More oviral transduction of constitutive-active Akt 1 (Adeno-myrAkt) increased expression of SM 1 and SM2. Conversely, dominant-negative Akt 1 increased SMemb expression. Next, we try to transfect target gene to VSMCs in vivo. Metallic stents coated with a polyurethane emulsion containing plasmid DNA were implanted in rabbit femoral arteries to evaluate transgene delivery and expression in the vessel wall. The expression of the plasmid-encoded marker genes, β-galactosidase, luciferase and green fluorescence protein (GEP), were evaluated at 7 days after implantation. The extent of transgene expression was dependent upon the quantity of DNA loaded onto the stent, no signal was detected in vessel segments that received bare metallic stents or polymer-coated stents lacking plasmid DNA. Finally, co-localization studies identified transgene expression in both vascular smooth muscle cells and macrophages. These data demonstrate the utility of coated stents for the local, dose-dependent delivety of genes to multiple cell types in the vessel wall. Less
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Takaishi H: "High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells"Biochemi Biophys Resse Comm. 305. 122-128 (2003)
Takaishi H:“高葡萄糖通过血管内皮细胞中的 p38 MAPK 加速 MCP-1 的产生”Biochemi Biophys Resse Comm.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sata M: "Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway"Arterioscler Thromb Vasc Biol. 22・8. 1305-1309 (2002)
Sata M:“曲尼司特通过 p21(WAF1) 依赖性途径减少平滑肌细胞增生的小鼠遗传学证据”Arterioscler Thromb Vasc Biol. 1305-1309 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sata M: "Mouse genetic evidence that tranilast reduces smooth Muscle cell hyperplasia via a p21(WAFI)-dependent pathway"Arterioscler Thromb Vasc Biol. 22(8). 1305-1309 (2002)
Sata M:“小鼠遗传证据表明曲尼司特通过 p21 (WAFI) 依赖性途径减少平滑肌细胞增生”Arterioscler Thromb Vasc Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
高橋 明広: "動脈硬化"循環器疾患最新の治療. 2004-2005. 433-438 (2004)
Akihiro Takahashi:“动脉硬化”心血管疾病的最新治疗方法2004-2005(2004)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
川嶋成乃亮: "脈管疾患の病態における内皮型NO合成酵素の作用の多様性"脈管学. 42. 291-296 (2002)
Narinosuke Kawashima:“内皮NO合酶在血管疾病病理学中的作用多样性”血管学42. 291-296 (2002)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
The mechanism of the enhanced sensitivityof anticancer drug andradioactive ray by the cox-2 inhibitor in oral squamous cell carcinoma
-
批准号:20791489
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2008
-
负责人:TANIGUCHI Takahiro
-
依托单位:
Identification of Adventitial cells and Molecular Mechanisms of Phenotypic Modulation in the vasclar remodeling after bolloon injury
-
批准号:11670678
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1999
-
负责人:TANIGUCHI Takahiro
-
依托单位:
Vascular Smooth Muscle Cell Singnal Transduction in Vascular Remodeling
-
批准号:09670719
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.73万
-
财政年份:1997
-
负责人:TANIGUCHI Takahiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
-
批准号:82370801
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:李峰
-
依托单位:
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
-
批准号:82371517
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:杨立群
-
依托单位:
新生儿坏死性小肠结肠炎中去泛素化酶USP15调控ILC3分化损伤肠道粘膜屏障的致病机制研究
-
批准号:82371711
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:吕志宝
-
依托单位:
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
-
批准号:82370906
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:代杰文
-
依托单位:
LIPUS促进微环境巨噬细胞释放CCL2诱导尿道周围平滑肌祖细胞定植与分化的机制研究
-
批准号:82370780
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:夏术阶
-
依托单位:
组蛋白乙酰化修饰ATG13激活自噬在牵张应力介导骨缝Gli1+干细胞成骨中的机制研究
-
批准号:82370988
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:经典
-
依托单位:
TNFAIP8/Hippo/SIX1轴调控软骨干细胞分化能力在颞下颌骨关节炎中的机制研究
-
批准号:82370980
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:沈佩
-
依托单位:
细胞命运决定中不同蛋白水平OCT4A差异性调控CITED2转录的机制研究
-
批准号:32100597
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周艳文
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位: